A Nature Communications study found that a single 25 mg dose of psilocybin produced an immediate rise in brain entropy and was associated with denser neural tracts one month later in 28 healthy volunteers. Participants reported improved wellbeing at two and four weeks and showed better cognitive-flexibility scores after the dose. Larger increases in brain entropy correlated with greater gains. The findings illuminate possible mechanisms for psilocybin's therapeutic effects but are preliminary and require larger clinical trials.
How a Single Dose of Psilocybin Reshapes the Brain — And Why That Matters
(Photo by Marek Piwnicki via Pexels)
A new study published in Nature Communications reports that a single 25 mg dose of psilocybin—the active compound in "magic mushrooms"—produced measurable changes in brain activity within an hour and detectable structural differences a month later in healthy volunteers.
What the researchers did
The within-subject trial enrolled 28 adults with no history of mental illness. Participants first completed a one-month placebo phase during which researchers measured psychological insight, wellbeing, and cognitive performance and scanned brain connectivity with fMRI. In a second phase the same volunteers received a single 25 mg dose of psilocybin—sufficient to induce a psychedelic experience—and were rescanned during the acute session and over the subsequent weeks.
(Photo by Marek Piwnicki via Pexels)
Key findings
Within an hour of dosing, investigators observed an increase in brain entropy, a term used to describe more complex, flexible and less predictable patterns of neural activity. Higher entropy suggests the brain is able to integrate and process a broader range of information than under ordinary conditions.
Importantly, some changes persisted beyond the acute effects. One month after the session, participants showed evidence of denser neural tracts and greater structural integrity—changes that contrast with typical age-related decline in white-matter structure.
(Photo by Marek Piwnicki via Pexels)
Behavioral and cognitive effects
Participants reported improved wellbeing on simple self-report items such as "I've been feeling optimistic about the future" and "I've been dealing with problems well" at both two and four weeks after dosing. Performance on a cognitive-flexibility test—designed to measure the ability to adapt thinking to new information—also improved across the group after psilocybin.
The study found a correlation between the magnitude of the immediate entropy increase (and likely intensity of the subjective experience) and the size of subsequent gains in wellbeing and cognitive performance.
"Psilocybin seems to loosen up stereotyped patterns of brain activity and give people the ability to revise entrenched patterns of thought," said Taylor Lyons, research associate at Imperial College London and the paper's first author.
Context and caveats
These results add to growing evidence that carefully controlled psychedelic sessions can produce measurable brain changes that align with therapeutic benefits. However, the study used a small sample of healthy volunteers and a within-subject design (placebo followed by active dose), so findings are preliminary. Larger, randomized controlled trials in clinical populations are needed to confirm whether similar effects occur in people with anxiety, depression, or addiction and to determine the durability and clinical significance of the observed brain changes.
Bottom line: A single controlled dose of psilocybin produced rapid changes in brain dynamics and was associated with structural and psychological benefits lasting at least a month in this small, healthy sample—supporting hypotheses about how psychedelics might aid psychotherapy, while underscoring the need for further research.
Help us improve.
